Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-12-09
1996-02-20
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514211, 514215, 514220, 5142248, 5142255, 5142262, 5142352, 514280, 514341, 514397, 514401, 514402, 514422, 514253, A61K 3154
Patent
active
054929075
ABSTRACT:
A method for treating a serious psychotic mental illness includes the step of administering to a patient in need of such treatment a combination of (i) an .alpha..sub.2 -adrenergic receptor antagonist and (ii) a D.sub.2 dopamine receptor antagonist, A pharmaceutical composition useful in the novel method includes an effective amount of the combination of the foregoing two ingredients together with a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4138484 (1979-02-01), Fuxe
patent: 4508715 (1985-04-01), Booth
patent: 4851416 (1989-07-01), Vizi
patent: 4882343 (1989-11-01), Cordi
patent: 5015654 (1991-05-01), Al-Damluji
"The Merck Manual of Diagnosis and Therapy," 14th Ed., p. 1462-1468 (1982).
Gordon, "Psychopharmacological Agents," vol. 1, pp. 28-34 (1964).
Doxey et al., "Comparison of the .alpha.-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine," Arch. Pharmacol. 325: 136-44 (1984).
Kane et al., "Clozapine for the Treatment-Resistant Schizophrenic," Arch. Gen. Psychiatry 45: 789-96 (1988).
Litman et al., ".alpha.2 Adrenergic Receptor Antagonist Strategies in the Pharmacology of Schizophrenia," Abstracts of Panels and Posters, Am. Coll. Neuropsychopharmacology, 30th Ann. Mtg. Dec. 9-13, 1991, Poster Session II.
Litman Robert E.
Pickar David
Potter William Z.
Shippen Michael L.
The United States of America as represented by the Department of
LandOfFree
Antipsychotic composition and method of treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antipsychotic composition and method of treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antipsychotic composition and method of treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1355997